Endovia Health Sciences, Inc. EDVA
to manage brands across viable growth segments within the consumer beverage industry. As a result of our lack of capital, we did not generate
revenue from February 2025 until March 2026 when we delivered tequila as described below. Our beverage operations have historically not
been profitable. Because of our lack of capital to generate revenue, our management reviewed strategic alternatives inside and outside
of the beverage industry. As a result, on March 4, 2026 the Company entered into a non-binding letter of intent setting forth the principal
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73.1K | $801.3K | $18.9M | $18.1M | $11.3M | $2.3M | $20.4K | $1.3M | $895.3K | $1.0M |
| Cost of revenue | — | $3.8M | $13.3M | $12.2M | $7.4M | $1.9M | $245.5K | $605.3K | $440.4K | $484.9K |
| Gross profit | $16.9K | -$119.8K | $5.6M | $5.9M | $3.9M | $363.6K | -$225.1K | $703.9K | $454.9K | $527.4K |
| SG&A | — | — | — | — | — | — | $204.1K | $194.3K | $162.5K | $136.1K |
| Total operating expenses | $14.2M | $9.8M | $20.9M | $27.3M | $33.0M | $18.0M | $4.3M | $637.2K | $612.1K | $577.4K |
| Operating income | -$14.2M | -$9.9M | -$15.3M | -$21.4M | -$29.1M | -$17.7M | -$4.5M | $66.7K | -$157.2K | -$50.0K |
| Interest expense | $2.5M | $3.7M | $1.9M | $251.5K | $442.8K | $2.0M | $665.2K | $5.7K | $4.5K | $4.7K |
| Pre-tax income | -$25.2M | -$23.8M | -$21.0M | -$21.7M | -$29.1M | $28.7M | -$5.1M | $68.2K | -$147.5K | -$48.8K |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$25.2M | -$23.8M | -$21.0M | -$21.7M | -$29.1M | $28.7M | -$5.1M | $68.2K | -$147.5K | -$48.8K |
| EPS, basic | -11.97 | -17.68 | — | — | -1.02 | -1.06 | -0.04 | 0.01 | — | — |
| EPS, diluted | -11.97 | -17.68 | — | — | -1.02 | -1.06 | -0.13 | 0.01 | -0.01 | 0.00 |
| Shares, diluted (wtd. avg.) | $2.2M | $1.3M | $1.1M | $37.4M | $28.9M | $18.5M | $11.9M | $11.4M | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $281.4K | $13.8K | $167.2K | $4.4M | $4.2M | $380.0K | $42.6K | $938.0K | — | — |
| Receivables | $15.7K | $192.0K | $890.6K | $1.8M | $1.1M | $484.9K | $11.4K | $301.0K | $151.3K | $206.3K |
| Inventory | $33.5K | $319.1K | $2.3M | $3.7M | $1.9M | $798.3K | $304.0K | $41.7K | — | — |
| Total current assets | $632.0K | $1.9M | $4.0M | $10.7M | $8.3M | $2.2M | $370.7K | $349.7K | $194.4K | $293.1K |
| Property, plant and equipment | $12.9K | $22.2K | $349.8K | $489.6K | $569.8K | $681.4K | $37.7K | $58.6K | $46.6K | $62.2K |
| Goodwill | — | — | $256.8K | $256.8K | $256.8K | $5.7M | — | — | — | — |
| Other intangibles | — | — | $4.5M | $4.9M | — | — | — | — | — | — |
| Total assets | $965.7K | $2.8M | $9.9M | $17.3M | $16.4M | $9.2M | $605.3K | $408.3K | $241.0K | $355.3K |
| Accounts payable | $4.8M | $3.6M | $4.4M | $3.4M | $1.9M | $1.5M | $703.9K | $331.0K | $226.2K | $209.1K |
| Short-term debt | — | — | — | — | — | — | $3.2K | $8.2K | $11.3K | $10.9K |
| Total current liabilities | $16.3M | $19.4M | $14.8M | $5.0M | $6.5M | $5.4M | $10.3M | $405.5K | $299.9K | $290.4K |
| Long-term debt | $3.4K | $2.0M | $457.7K | $2.5M | $0 | $1.2M | $2.1K | $5.5K | $14.0K | $25.3K |
| Total liabilities | $16.3M | $21.4M | $15.5M | $8.0M | $7.5M | $9.3M | $10.4M | $411.0K | $313.9K | $315.7K |
| Retained earnings | -$181.9M | -$155.8M | -$133.3M | -$112.3M | -$90.6M | -$61.6M | -$31.8M | -$248.2K | -$316.4K | -$168.8K |
| Total equity | -$15.3M | -$18.6M | -$5.6M | $9.3M | $8.9M | -$9.4M | -$9.8M | -$7.8M | -$72.9K | $39.7K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.8M | -$7.3M | -$10.2M | -$14.0M | -$14.7M | -$21.3M | -$2.7M | $62.4K | -$17.6K | $32.1K |
| Depreciation and amortisation | $148.1K | $148.2K | $153.9K | $182.9K | $156.8K | $55.6K | $19.8K | $62.8K | $71.9K | $55.8K |
| Stock-based compensation | $8.6M | $2.4M | $1.2M | $7.4M | $4.0M | $2.3M | $1.6M | $0 | — | — |
| Capital expenditure | — | $3.2K | $14.1K | $102.7K | $0 | $91.1K | $12.6K | $75.6K | $58.3K | $58.4K |
| Investing cash flow | — | -$3.2K | -$14.1K | -$102.7K | $0 | -$768.6K | -$12.6K | -$67.6K | -$42.2K | -$52.1K |
| Financing cash flow | $5.1M | $7.5M | $6.1M | $14.4M | $19.0M | $22.5M | $1.8M | -$5.8K | $16.1K | $74.3K |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001731122-26-000640.
Others in SIC 2080
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| KO | COCA COLA CO | $378.92B | 29.0x | 1.9% |
| PEP | PEPSICO INC | $187.85B | 22.9x | 2.3% |
| KDP | Keurig Dr Pepper Inc. | $44.35B | 21.3x | 8.2% |
| BF-B | BROWN FORMAN CORP | $12.26B | 17.5x | -1.2% |
| PRMB | Primo Brands Corp | $7.97B | 137.5x | 29.3% |
| COCO | Vita Coco Company, Inc. | $3.16B | 46.3x | 18.2% |
| BRCC | BRC Inc. | $1.03B | — | 1.7% |
| WEST | Westrock Coffee Co | $756.6M | — | 39.8% |